The European Medicines Agency's safety committee is also looking
into cases of blood clots in the vein with Johnson & Johnson's
COVID-19 vaccine, the regulator said, adding that the issue was
distinct from a rare side-effect identified earlier.
(Reporting by Pushkala Aripaka in Bengaluru; Editing by Ramakrishnan
M.)
[© 2021 Thomson Reuters. All rights
reserved.] Copyright 2021 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content |